Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David K Johnson

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Applied Neuropsychology. Adult|January 25, 2022
Measurement invariance of a neuropsychological battery across urban and rural older adults in Costa RicaEsmeralda Valdivieso-Mora, Monica Salazar-Villanea, David K Johnson
Alzheimer Disease and Associated Disorders|July 3, 2009
Body mass index and cognitive decline in mild cognitive impairmentBenjamin B Cronk, David K Johnson, Jeffrey M Burns, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2012
Challenges for assessing the performance of biomass degrading biocatalystsMichael E Himmel, Stephen R Decker, David K Johnson
Archives of Neurology|September 13, 2006
Accelerated weight loss may precede diagnosis in Alzheimer diseaseDavid K Johnson, Consuelo H Wilkins, John C Morris
Neurology|October 26, 2005
Verbal and visuospatial deficits in dementia with Lewy bodiesDavid K Johnson, John C Morris, James E Galvin
Neurodegenerative Disease Management|October 7, 2014
Should we disclose amyloid imaging results to cognitively normal individuals?Joshua D Grill, David K Johnson, Jeffrey M Burns
Journal of Inflammation (London, England)|March 15, 2012
Anti-inflammatory effects of methoxyphenolic compounds on human airway cellsKenneth R Houser, David K Johnson, Faoud T Ishmael
ACS Medicinal Chemistry Letters|November 18, 2021
The Discovery of Conformationally Constrained Bicyclic Peptidomimetics as Potent Hepatitis C NS5A InhibitorsWieslaw M Kazmierski, Nagaraju Miriyala, David K Johnson, et al.
Methods in Enzymology|June 17, 2024
Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axisJustin T Douglas, David K Johnson, Anuradha Roy, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2021
Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease DementiaTaylor Rigby, David K Johnson, Angela Taylor, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Applied Neuropsychology. Adult|January 25, 2022
Measurement invariance of a neuropsychological battery across urban and rural older adults in Costa RicaEsmeralda Valdivieso-Mora, Monica Salazar-Villanea, David K Johnson
Alzheimer Disease and Associated Disorders|July 3, 2009
Body mass index and cognitive decline in mild cognitive impairmentBenjamin B Cronk, David K Johnson, Jeffrey M Burns, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 31, 2012
Challenges for assessing the performance of biomass degrading biocatalystsMichael E Himmel, Stephen R Decker, David K Johnson
Archives of Neurology|September 13, 2006
Accelerated weight loss may precede diagnosis in Alzheimer diseaseDavid K Johnson, Consuelo H Wilkins, John C Morris
Neurology|October 26, 2005
Verbal and visuospatial deficits in dementia with Lewy bodiesDavid K Johnson, John C Morris, James E Galvin
Neurodegenerative Disease Management|October 7, 2014
Should we disclose amyloid imaging results to cognitively normal individuals?Joshua D Grill, David K Johnson, Jeffrey M Burns
Journal of Inflammation (London, England)|March 15, 2012
Anti-inflammatory effects of methoxyphenolic compounds on human airway cellsKenneth R Houser, David K Johnson, Faoud T Ishmael
ACS Medicinal Chemistry Letters|November 18, 2021
The Discovery of Conformationally Constrained Bicyclic Peptidomimetics as Potent Hepatitis C NS5A InhibitorsWieslaw M Kazmierski, Nagaraju Miriyala, David K Johnson, et al.
Methods in Enzymology|June 17, 2024
Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axisJustin T Douglas, David K Johnson, Anuradha Roy, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2021
Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease DementiaTaylor Rigby, David K Johnson, Angela Taylor, et al.
Pageof 16